Delivery Order SPE2DB20D3303-SPE2DB24FZ9S5

Award Date 6/11/24
Potential Completion Date 7/3/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The award, valued at $8,575.36, has an ultimate completion date of July 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $17,150.74 firm fixed-price delivery order is for the provision of Calquence 100 mg tablets, a prescription medication. The contract has an ultimate completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The firm-fixed-price delivery order, valued at $27,968.85, has an ultimate completion date of March 27, 2025. The award is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award, valued at $17,150.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, with a completion date of September 26, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $17,150.74, is for the delivery of 100 mg CALQUENCE tablets over a period ending on December 4, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a Delivery Order (DO) valued at $11,187.56 made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CALQUENCE 100 MG TABLET 60S, a specialty pharmaceutical product, with a period of performance through April 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $5,593.77 for the supply of CALQUENCE 100 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price arrangement with a period of performance through February 25, 2025. This award is part of a larger Indefinite Delivery Contract valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $5,593.77 Firm Fixed Price Delivery Order for the provision of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $8,871.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $8,871.74. The place of performance is Conshohocken, Pennsylvania. The contract is a firm fixed-price arrangement and does...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ9S5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of CALQUENCE 100 MG TABLET 60S. The contract has a ceiling value of $25,726.08 and is a firm fixed-price delivery order that runs through July 3, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was made on a full and open competition basis without any set-aside designation.

Generated 9/10/24, 9:19 AM